Shai Shimony, MD

Shai Shimony, MD

Dr Shimony's clinical focus is on care of patients with acute leukemia with special interest in acute myeloid leukemia, acute lymphoblastic leukemia and blastic plasmacytoid dentritic cell neoplasm. Dr Shimony's research interest is utilizing real-world data to perform correlative studies and understanding the impact of genetic mutations on patient outcomes.

Related Videos

Shai Shimony, MD, Molecular Ontogeny in AML Video

Shai Shimony, MD, Molecular Ontogeny in AML

A study led by Shai Shimony, MD, Dana-Farber, revealed the significant impact of molecular ontogeny classification on outcomes among newly diagnosed acute myeloid leukemia patients treated with hypomethylating agents (HMA) +/- venetoclax (VEN).